EMA — authorised 2 April 2013
- Status: approved
🇪🇺 Perjeta in European Union
EMA authorised Perjeta on 2 April 2013
Marketing authorisation
Perjeta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Perjeta approved in European Union?
Yes. EMA authorised it on 2 April 2013.
Who is the marketing authorisation holder for Perjeta in European Union?
Roche is the originator. The local marketing authorisation holder may differ — check the official source linked above.